Evidence map›Paper›PMID 28012572›Full record

SynthesisTrends in genetics : TIG2017

Mammalian Polycistronic mRNAs and Disease.

Timofey A Karginov, Daniel Parviz Hejazi Pastor, Bert L Semler, Christopher M Gomez

Abstract readSystematic Review
In one paragraph

Synthesis in Trends in genetics : TIG, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Split genetically encoded calcium indicators for interorganellar junctions.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Article
  3. Review
  4. Gene regulation inCurrent research in parasitology & vector-borne diseases · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Understanding the defense mechanism ofFrontiers in plant science · 2024
    Article
  9. Article
  10. iScience · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Efficient Amber SuppressionACS synthetic biology · 2022
    Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Timofey A KarginovDepartment of Neurology, University of Chicago, Chicago, IL, USA.
Daniel Parviz Hejazi PastorDepartment of Neurology, University of Chicago, Chicago, IL, USA.
Bert L SemlerDepartment of Microbiology & Molecular Genetics, School of Medicine, University of California, Irvine, CA, USA.
Christopher M GomezDepartment of Neurology, University of Chicago, Chicago, IL, USA. Electronic address: cgomez@neurology.bsd.uchicago.edu.

Funding

A novel role for a bicistronic calcium channel gene in neurodevelopment and neurodegenerationR01NS082788 · NINDS · UNIVERSITY OF CHICAGO · PI GOMEZ, CHRISTOPHER MANUEL · 2014 to 2019
$2.8M
Overlapping cistrons in a family of ion channel genesR01NS094665 · NINDS · UNIVERSITY OF CHICAGO · PI GOMEZ, CHRISTOPHER MANUEL · 2015 to 2019
$2.1M
NINDS NIH HHS R01 NS082788NINDS NIH HHS R01 NS094665
6 · The paper itself

Abstract

Our understanding of gene expression has come far since the 'one-gene one-polypeptide' hypothesis proposed by Beadle and Tatum. In this review, we address the gradual recognition that a growing number of polycistronic genes, originally discovered in viruses, are being identified within the mammalian genome, and that these may provide new insights into disease mechanisms and treatment. We carried out a systematic literature review identifying 13 mammalian genes for which there is evidence for polycistronic expression via translation through an internal ribosome entry site (IRES). Although the canonical mechanism of translation initiation has been studied extensively, here we highlight a process of noncanonical translation, IRES-mediated translation, that is a growing source for understanding complex inheritance, the elucidation of disease mechanisms, and the discovery of novel therapeutic targets. Identification of additional polycistronic genes may provide new insights into disease therapy and allow for new discoveries of both translational and disease mechanisms.

Indexed as

Protein BiosynthesisAnimalsGenetic Diseases, InbornHumansInternal Ribosome Entry SitesMammalsMolecular Targeted TherapyRNA, MessengerInternal Ribosome Entry SitesRNA, Messengerbicistroniccap-independenteIFIRESITAFpolycistronic

Identifiers

PMID28012572
PMCPMC5285393

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.